{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:03:47Z","timestamp":1793862227741,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.vaccine.2008.09.009","type":"journal-article","created":{"date-parts":[[2008,9,21]],"date-time":"2008-09-21T09:22:07Z","timestamp":1221988927000},"page":"6077-6082","source":"Crossref","is-referenced-by-count":218,"title":["Adverse event reports following yellow fever vaccination"],"prefix":"10.1016","volume":"26","author":[{"given":"Nicole P.","family":"Lindsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy A.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Miles","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison F.","family":"Hinckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Marano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary W.","family":"Brunette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Horan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Erin","family":"Staples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis E.","family":"Kozarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"RR-17","key":"10.1016\/j.vaccine.2008.09.009_bib1","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2008.09.009_bib2","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.009_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4269\/ajtmh.1999.60.1045","article-title":"Comparison of the immunogenicity and safety of two 17D yellow fever vaccines","volume":"60","author":"Lang","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.009_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.009_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4269\/ajtmh.2005.72.339","article-title":"Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial","volume":"72","author":"Pfister","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.009_bib6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","article-title":"Anaphylaxis from yellow fever vaccine","volume":"103","author":"Kelso","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"25","key":"10.1016\/j.vaccine.2008.09.009_bib7","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.009_bib8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"Martin","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.009_bib9","first-page":"244","article-title":"Age-related risk of adverse events following yellow fever vaccination in Australia","volume":"28","author":"Lawrence","year":"2004","journal-title":"Commun Dis Intell"},{"issue":"9438","key":"10.1016\/j.vaccine.2008.09.009_bib10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"History of thymoma and yellow fever vaccination","volume":"364","author":"Barwick","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2008.09.009_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3928\/0090-4481-20040901-11","article-title":"The role of the vaccine adverse event reporting system (VAERS) in monitoring vaccine safety","volume":"33","author":"Iskander","year":"2004","journal-title":"Pediatr Ann"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.009_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the vaccine adverse event reporting system","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"31","key":"10.1016\/j.vaccine.2008.09.009_bib13","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.09.009_bib14","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.009_bib15","first-page":"1","article-title":"Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)\u2014United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"issue":"13","key":"10.1016\/j.vaccine.2008.09.009_bib16","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.vaccine.2005.11.057","article-title":"Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults","volume":"24","author":"Cook","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.009_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01586187","article-title":"Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies","volume":"15","author":"Beyer","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6910","key":"10.1016\/j.vaccine.2008.09.009_bib18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bmj.307.6910.988","article-title":"Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial","volume":"307","author":"Govaert","year":"1993","journal-title":"BMJ"},{"issue":"25","key":"10.1016\/j.vaccine.2008.09.009_bib19","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1016\/j.vaccine.2007.04.017","article-title":"Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults","volume":"25","author":"Cook","year":"2007","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2008.09.009_bib20","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","article-title":"Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.009_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trstmh.2006.04.001","article-title":"Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998-2002","volume":"101","author":"Tuboi","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.09.009_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4269\/ajtmh.1929.s1-9.233","article-title":"Observations on the age and sex incidence of deaths and recoveries in the yellow fever epidemic in the department of Lambayeque P, in 1921","volume":"9","author":"Hanson","year":"1929","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.009_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.SMJ.0000157537.11806.DC","article-title":"Rare case of fatal yellow fever vaccine-associated viscerotropic disease","volume":"98","author":"Gerasimon","year":"2005","journal-title":"South Med J"},{"issue":"50","key":"10.1016\/j.vaccine.2008.09.009_bib24","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.009_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2006.02.005","article-title":"Yellow fever vaccine-associated viscerotropic disease and death in Spain","volume":"36","author":"Doblas","year":"2006","journal-title":"J Clin Virol"},{"issue":"9276","key":"10.1016\/j.vaccine.2008.09.009_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"9276","key":"10.1016\/j.vaccine.2008.09.009_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.09.009_bib28","doi-asserted-by":"crossref","DOI":"10.1086\/587844","article-title":"Immune response during adverse events after 17D-derived yellow fever vaccination in Europe","author":"Bae","year":"2008","journal-title":"J Infect Dis"},{"issue":"9296","key":"10.1016\/j.vaccine.2008.09.009_bib29","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(01)06914-8","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Adhiyaman","year":"2001","journal-title":"Lancet"},{"issue":"9296","key":"10.1016\/j.vaccine.2008.09.009_bib30","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(01)06917-3","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Werfel","year":"2001","journal-title":"Lancet"},{"issue":"9296","key":"10.1016\/j.vaccine.2008.09.009_bib31","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0140-6736(01)06916-1","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Troillet","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.009_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S0950268804002602","article-title":"Risk of fatal adverse events associated with 17DD yellow fever vaccine","volume":"132","author":"Struchiner","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"13","key":"10.1016\/j.vaccine.2008.09.009_bib33","first-page":"936","article-title":"Adverse effects of attenuated yellow fever vaccine with multiple organ injury\u2014a case report","volume":"85","author":"Zhou","year":"2005","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.009_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4269\/ajtmh.2006.75.333","article-title":"Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996\u20132004","volume":"75","author":"Vellozzi","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.009_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/590187","article-title":"Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes","volume":"198","author":"Pulendran","year":"2008","journal-title":"J Infect Dis"},{"issue":"9276","key":"10.1016\/j.vaccine.2008.09.009_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2008.09.009_bib37","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2006.01.009","article-title":"Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil","volume":"24","author":"Engel","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.009_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1708-8305.2008.00209.x","article-title":"Yellow fever-associated viscerotropic disease in Barcelona","volume":"15","author":"Munoz","year":"2008","journal-title":"Spain. J Travel Med"},{"key":"10.1016\/j.vaccine.2008.09.009_bib39","unstructured":"CDC. Adverse events associated with 17D-derived yellow fever vaccination\u2014United States, 2001\u20132002. MMWR 2002;51(44):989\u201393."},{"key":"10.1016\/j.vaccine.2008.09.009_bib40","unstructured":"CDC. Health information for international travel 2008. Atlanta: US Department of Health and Human Services PHS; 2007."},{"issue":"10","key":"10.1016\/j.vaccine.2008.09.009_bib41","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/340104","article-title":"Prevention of yellow fever in persons traveling to the tropics","volume":"34","author":"Monath","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2008.09.009_bib42","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance systems for vaccine adverse events","volume":"85","author":"Rosenthal","year":"1995","journal-title":"Am J Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:06:10Z","timestamp":1557792370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08012309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":42,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0264410X08012309"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}